Source: centralcharts

Press Release: Agenus : Agenus Announces Botensilimab and Balstilimab Presentations at ASCO 2025

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced three upcoming presentations at the 2025 American Society of Clinical Oncology (ASCO)

Read full article »
Agenus's Competitors | Agenus's News | Agenus's Financials
Stay up-to-date with the latest news on Agenus
Annual Revenue
$100-500M
Employees
250-500
Garo H. Armen's photo - Chairman & CEO of Agenus

Chairman & CEO

Garo H. Armen

CEO Approval Rating

85/100

Read more
Stay up-to-date with the latest news on Agenus